Indications
This medicinal product is for diagnostic use only. Rapiscan is a selective coronary vasodilator for use as a pharmacological stress agent for radionuclide myocardial perfusion imaging (MPI) in adult patients unable to undergo adequate exercise stress.
Composition
- Active substance
- regadenoson
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rapiscan
- Active substance
- regadenoson
- ATC code
- C01EB21
- Therapeutic area
- Myocardial Perfusion Imaging
- Marketing authorisation holder
- GE Healthcare AS
- Status
- Authorised